The impact of topical cyclosporine A emulsion 0.05% on the outcomes of patients with keratoconjunctivitis sicca

Author： Stonecipher Karl   Perry Henry D.   Gross Robert H.   Kerney Donna L.  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.21, Iss.7, 2005-07, pp. : 1057-1064

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Topical cyclosporine‐A in Vernal Keratoconjunctivitis, when how and how long

By  

ACTA OPHTHALMOLOGICA, Vol. 94, Iss. S256, 2016-10 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Tacrolimus vs. cyclosporine eyedrops in severe cyclosporine‐resistant vernal keratoconjunctivitis: A randomized, comparative, double‐blind, crossover study

By  

PEDIATRIC ALLERGY AND IMMUNOLOGY, Vol. 26, Iss. 3, 2015-05 ,pp. : 256-261

John Wiley & Sons Inc

Access to resources Recommend Favorite

Impact of the emergency department streaming decision on patients' outcomes

By  

INTERNAL MEDICINE JOURNAL, Vol. 45, Iss. 12, 2015-12 ,pp. : 1241-1247

John Wiley & Sons Inc

Access to resources Recommend Favorite

Semi‐fluorinated alkanes for topical delivery of Cyclosporine

By  

ACTA OPHTHALMOLOGICA, Vol. 94, Iss. S256, 2016-10 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Improvements in patient‐reported outcomes in patients with psoriasis receiving etanercept plus topical therapies: results from REFINE

By  

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 29, Iss. 8, 2015-08 ,pp. : 1555-1561

John Wiley & Sons Inc

Access to resources Recommend Favorite